Northeast Financial Consultants’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,399
| Closed | -$779K | – | 319 |
|
|
2020
Q1 | $779K | Sell |
4,399
-1,736
| -28% | -$307K | 0.09% | 138 |
|
|
2019
Q4 | $1.17M | Sell |
6,135
-146
| -2% | -$27.9K | 0.1% | 120 |
|
|
2019
Q3 | $1.06M | Hold |
6,281
| – | – | 0.11% | 128 |
|
|
2019
Q2 | $1.05M | Hold |
6,281
| – | – | 0.11% | 125 |
|
|
2019
Q1 | $920K | Buy |
+6,281
| New | +$920K | 0.1% | 126 |
|
|
2018
Q3 | – | Sell |
-5,805
| Closed | -$967K | – | 181 |
|
|
2018
Q2 | $967K | Hold |
5,805
| – | – | 0.3% | 49 |
|
|
2018
Q1 | $976K | Buy |
5,805
+1,899
| +49% | +$319K | 0.33% | 47 |
|
|
2017
Q4 | $638K | Hold |
3,906
| – | – | 0.21% | 80 |
|
|
2017
Q3 | $801K | Hold |
3,906
| – | – | 0.29% | 56 |
|
|
2017
Q2 | $950K | Buy |
3,906
+1,328
| +52% | +$323K | 0.37% | 53 |
|
|
2017
Q1 | $616K | Sell |
2,578
-28
| -1% | -$6.69K | 0.26% | 69 |
|
|
2016
Q4 | $547K | Hold |
2,606
| – | – | 0.24% | 72 |
|
|
2016
Q3 | $600K | Buy |
2,606
+146
| +6% | +$33.6K | 0.25% | 70 |
|
|
2016
Q2 | $568K | Sell |
2,460
-1,345
| -35% | -$311K | 0.25% | 68 |
|
|
2016
Q1 | $1.02M | Hold |
3,805
| – | – | 0.54% | 36 |
|
|
2015
Q4 | $1.19M | Buy |
3,805
+425
| +13% | +$133K | 0.62% | 33 |
|
|
2015
Q3 | $919K | Hold |
3,380
| – | – | 0.47% | 41 |
|
|
2015
Q2 | $1.03M | Buy |
+3,380
| New | +$1.03M | 0.46% | 43 |
|